Shares of Insulet (NASDAQ:PODD) surged 13.3% last month, according to data from S&P Global Market Intelligence. The S&P 500 was flat in January. The Boston-area healthcare company is the leader in tubeless insulin pump technology with its Omnipod pump.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,